alanine has been researched along with Acrania in 4 studies
Alanine: A non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL NERVOUS SYSTEM.
alanine : An alpha-amino acid that consists of propionic acid bearing an amino substituent at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A mutation in the gene 5,10-methylenetetrahydrofolate reductase (MTHFR), leading to altered homocysteine metabolism, has been identified in parents and fetuses with fetal neural tube defects." | 7.70 | Role of amniotic fluid homocysteine level and of fetal 5, 10-methylenetetrahydrafolate reductase genotype in the etiology of neural tube defects. ( Acton, S; Johanning, GL; Johnston, KE; Owen, J; Tamura, T; Wenstrom, KD, 2000) |
| "A specific gene mutation leading to altered homocysteine metabolism has been identified in parents and fetuses with neural tube defects (NTDs)." | 3.70 | Amniotic fluid homocysteine levels, 5,10-methylenetetrahydrafolate reductase genotypes, and neural tube closure sites. ( Acton, S; Cliver, S; Johanning, GL; Johnston, KE; Owen, J; Tamura, T; Wenstrom, KD, 2000) |
| "A mutation in the gene 5,10-methylenetetrahydrofolate reductase (MTHFR), leading to altered homocysteine metabolism, has been identified in parents and fetuses with fetal neural tube defects." | 3.70 | Role of amniotic fluid homocysteine level and of fetal 5, 10-methylenetetrahydrafolate reductase genotype in the etiology of neural tube defects. ( Acton, S; Johanning, GL; Johnston, KE; Owen, J; Tamura, T; Wenstrom, KD, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khan, MSI | 1 |
| Nabeka, H | 1 |
| Akbar, SMF | 1 |
| Al Mahtab, M | 1 |
| Shimokawa, T | 1 |
| Islam, F | 1 |
| Matsuda, S | 1 |
| Wenstrom, KD | 2 |
| Johanning, GL | 2 |
| Owen, J | 2 |
| Johnston, KE | 2 |
| Acton, S | 2 |
| Cliver, S | 1 |
| Tamura, T | 2 |
| García-Fragoso, L | 1 |
| García-García, I | 1 |
| de la Vega, A | 1 |
| Renta, J | 1 |
| Cadilla, CL | 1 |
4 other studies available for alanine and Acrania
| Article | Year |
|---|---|
Risk of congenital birth defects during COVID-19 pandemic: Draw attention to the physicians and policymakers.
Topics: Adenosine Monophosphate; Alanine; Antimalarials; Antiviral Agents; Congenital Abnormalities; COVID-1 | 2020 |
Amniotic fluid homocysteine levels, 5,10-methylenetetrahydrafolate reductase genotypes, and neural tube closure sites.
Topics: 5,10-Methylenetetrahydrofolate Reductase (FADH2); Alanine; Amino Acid Substitution; Amniotic Fluid; | 2000 |
Role of amniotic fluid homocysteine level and of fetal 5, 10-methylenetetrahydrafolate reductase genotype in the etiology of neural tube defects.
Topics: 5,10-Methylenetetrahydrofolate Reductase (FADH2); Alanine; Amino Acid Substitution; Amniotic Fluid; | 2000 |
Presence of the 5,10-methylenetetrahydrofolate reductase C677T mutation in Puerto Rican patients with neural tube defects.
Topics: Adult; Alanine; Alleles; Amino Acid Substitution; Female; Genetic Predisposition to Disease; Hispani | 2002 |